News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Arrowhead Research Corporation (ARWR) to Present at Rodman & Renshaw Annual Global Investment Conference


9/5/2012 9:46:14 AM

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that its President and Chief Executive Officer, Dr. Chris Anzalone, is presenting at the Rodman and Renshaw Annual Global Investment Conference on Monday September 10th at the Waldorf Astoria in New York City. Dr. Anzalone will present a company overview at 10:50 AM Eastern time and will be part of a panel discussion titled, “Obesity: Dawn of a New Era of Pharmacologic Therapy,” at 12:30 PM.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES